CVE-2025-59852 HCL CVE debrief

Who should care

Defenders responsible for HCL DFXAnalytics deployments should assess exposure and prioritize verification of insufficient transport layer protection. This includes reviewing HCL DFXAnalytics deployments, verifying data transmission encryption, and assessing exposure of sensitive information. Security teams and vulnerability management teams should also be aware of this vulnerability and its potential impacts.

Why it matters

CVE-2025-59852 is a low-severity vulnerability in HCL DFXAnalytics that allows an attacker to compromise the confidentiality, integrity, and authentication of sensitive information due to insufficient transport layer protection. Defenders responsible for HCL DFXAnalytics deployments should assess exposure and prioritize verification of data transmission encryption.

• Compromise of confidentiality of sensitive information
• Compromise of integrity of sensitive information
• Compromise of authentication of sensitive information
• Verification of data transmission encryption in HCL DFXAnalytics

Technical summary

HCL DFXAnalytics is affected by an Insufficient Transport Layer Protection vulnerability. The vulnerability allows an attacker to compromise the confidentiality, integrity, and authentication of sensitive information as data is transmitted over the network without encryption. This issue has a CVSS score of 3.7 and is considered LOW severity. Defenders should assess exposure and prioritize verification of HCL DFXAnalytics deployments for insufficient transport layer protection and verify data transmission encryption.

Defensive priority

Assess exposure and prioritize verification of HCL DFXAnalytics deployments for insufficient transport layer protection.

Recommended defensive actions

• Review HCL DFXAnalytics deployments for insufficient transport layer protection
• Verify data transmission encryption in HCL DFXAnalytics
• Assess exposure of sensitive information in HCL DFXAnalytics deployments
• Confirm whether affected product deployments exist in managed environments and assign an owner for follow-up
• Review the supplied official advisory or CVE record to validate affected scope, severity, and vendor guidance
• Plan vendor-supported updates or mitigations through normal change control where exposure is confirmed
• Check relevant monitoring, detection, and logs for exposed assets that need extra review

Evidence notes

The CVE description notes that HCL DFXAnalytics transmits data over the network without encryption, potentially allowing attackers to compromise confidentiality, integrity, and authentication of sensitive information. The vulnerability has a CVSS score of 3.7 and is classified as LOW severity. There is no information on known or unknown affected scope beyond the HCL DFXAnalytics product.

Sources and references

Methodology and review provenance

AI-assisted synthesis based on stored public vulnerability evidence. System validation, approval state, and publication status do not by themselves establish human review of this revision. PatchSiren helps prioritize defensive review and does not prove exposure or remediation on any system.